Projects

Funded by BMBF (Ministry for Education and Research ): Baden-Württemberg Consortium for Addiction Research (Speaker: Prof. Dr. Karl Mann):

• Individually adapted therapy for alcoholism A. Heinz, K. Mann
• Developmental pathways to tobacco abuse A. Heinz, K. Mann
• Individually adapted therapy for alcoholism R. Spanagel; Department of Psychopharmacology
• Health economics for the treatment of alcoholism, smoking and drug addiction. H. Salize, Centre for Psychiatric Epidemiology and Health Service Research, K. Mann
• DNA bank "addiction" G. Schumann, Department of Psychiatry, K. Mann
• Biostatistical Center. Division of Biostatistics, S. Wellek
• Coordination Centre. K. Mann, Th. Hintz, S. Großmann

Projects for „Alcohol Addiction“

• MR-spectroscopy in cannabis consuming probands. D. Hermann, H. Welzel, G. Ende, G. Skopp, K. Mann
• "Alcohol addiction (Speaker: P. Seeburg and H. Moyner) Coordination: R. Spanagel, G. Schumann

Funded by the DFG (German Society for Research):

• Imaging studies on stimulus induced alcohol craving with fMRT and PET (DFG Az: He 2597/4-1). A. Heinz, J. Wrase, K. Mann in cooperation with with the NMR research group at the CIMH (PD Dr. Braus), the Department of Neuropsychology at the CIMH (Prof. Flor) and the University of Mainz (Prof. Bartenstein).
• Pathogenetics and reversibility of alcohol-induced brain alterations (DFG Az: Ma L013/1-1). K. Mann, A. Heinz in cooperation with the Department of Neuropsychology at the CIMH (Dr. Ende, Prof. Flor) and the NMR research group at the CIMH (Prof. Henn, PD Dr. Braus, Dr. Ende).
• Serotonintransporter in alcoholic, depressiv, obsessiv compulsive patients M. Smolka, K. Mann (Mannheim), A. Batra, R. Bares (Tübingen), A. Heinz (Berlin)
• The neurobiology of nicotine withdrawal. Evidence from functional magnetic resonance imaging, M. N. Smolka, K. Mann, A. Heinz

Funded by the federal state of Baden-Württemberg:

• Activity of the endogenous opioid system as a therapy predictor in alcohol-dependent patients – a PET study. The status of opioid receptors is to be characterised with the aid of PET. R. Bares, K. Mann, D. Hermann
• The role of endotoxine in alcohol-dependence and alcohol-induced organic diseases. K. Mann, S. Scharwatz in cooperation with the Faculty of Clinical Medicine, Mannheim at the University of Heidelberg, II. Medical Clinic (Prof. Singer)

CIMH Research Fund:

• u-opioid receptor positron emission tomography (PET) and MR-spectroscopy in cannabis abusing patients. D. Hermann, A. Heinz, R. Bares, K. Mann

Funded by the industry:

• Oxcarbazepin vs Campral in alcohol relapse prevention. B. Croissant, A. Diehl, K. Mann
• Comparison of the efficacy and safety of SR141716 20mg/day vs. placebo for prevention of relapse in recently detoxified alcohol dependent patients. M. Smolka, K. Mann
• Drug prevention in the workplace. B. Croissant, K. Hupfer, A. Zober, K. Mann
• Prevention by drug prevention in the workplace. B. Croissant, Ch. Neuberger, S. Löber, U. Vogel, K. Mann
• A combination therapy of tiaprid and carbamazepin in outpatient alcohol detoxication. B. Croissant, A. Diehl, K. Mann

EU-Project

• Primary Health Care European Project an Alcohol. M. Smolka